A Phase 3, Multi-Center Study of Gemcitabine/Carboplatin, With or Without BSI-201, in Patients With ER-, PR-, and Her2-Negative Metastatic Breast Cancer
A phase 3 trial of Gemcitabine, Carboplatin and Iniparib in Breast cancer, run by Sanofi, completed.
Overview
A Phase 3, Multi-Center Study of Gemcitabine/Carboplatin, With or Without BSI-201, in Patients With ER-, PR-, and Her2-Negative Metastatic Breast Cancer is a phase 3 interventional study registered as NCT00938652 by Sanofi, with 519 participants recorded, started 2009-07 and reaching its primary completion in 2011-01. Interventions recorded: gemcitabine/carboplatin, Iniparib. Conditions recorded: Breast Cancer.
Linked to the drug Iniparib because the registry names it among its interventions and Breast cancer among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialStudy of SAR240550 (BSI-201) in Combination With Gemcitabine/Carboplatin, in Patients With Metastatic Triple Negative Breast Cancer
Shares Iniparib, Sanofi, Breast cancer (all types), Gemcitabine and the tag pipeline.
- TrialTwo Regimens of SAR240550/Weekly Paclitaxel and Paclitaxel Alone as Neoadjuvant Therapy in Triple Negative Breast Cancer Patients
Shares Iniparib, Sanofi, Breast cancer (all types) and the tag pipeline.
- TrialTusamitamab Ravtansine Monotherapy and in Combination in Patients With CEACAM5-positive Advanced Solid Tumors
Shares Sanofi, Breast cancer (all types), Gemcitabine and the tag pipeline.
- TrialOptimization of Dynamic Neoadjuvant Therapy Strategies for HER2-Positive Breast Cancer Based on HER2-PET/CT Molecular Imaging
Shares Breast cancer (all types), Carboplatin and the tag pipeline.
- TrialTusamitamab Ravtansine (SAR408701) in Combination With Pembrolizumab and Tusamitamab Ravtansine (SAR408701) in Combination With Pembrolizumab and Platinum-based Chemotherapy With or Without Pemetrexed in Patients With NSQ NSCLC
Shares Sanofi, Carboplatin and the tag pipeline.
- TrialPhase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
Shares Gemcitabine, Carboplatin and the tag pipeline.
- TrialSafety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With Chemotherapy
Shares Gemcitabine, Carboplatin and the tag pipeline.
- TrialA Phase Ib/II Study of AK112 in Combination With AK117 in Advanced Malignant Tumors
Shares Gemcitabine, Carboplatin and the tag pipeline.